Reata Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
RETA Reata Pharmaceuticals Inc
BAC Bank of America Corp
AZN AstraZeneca PLC
CLZNY Clariant AG
CARR Carrier Global Corp
KBH KB Home
SMIT Schmitt Industries Inc
OOMA Ooma Inc
SEDG Solaredge Technologies Inc
CELH Celsius Holdings Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with a range of serious or life-threatening diseases. The Company's lead product candidates include bardoxolone methyl, which is being studied in Phase III trial for the treatment of pulmonary arterial hypertension (PAH), associated with connective tissue disease (CTD-PAH), as well as a Phase II trial for the treatment of pulmonary hypertension due to interstitial lung disease (PH-ILD), and PAH, each of which are subsets of pulmonary hypertension (PH), Omaveloxolone, which is in Phase II clinical development for the treatment of multiple diseases, including Friedreich's ataxia, mitochondrial myopathies and metastatic melanoma.

Closing Price
$157.26
Day's Change
5.37 (3.54%)
Bid
--
Ask
--
B/A Size
--
Day's High
157.69
Day's Low
153.05
Volume
(Light)
Volume:
127,780

10-day average volume:
295,760
127,780
  • Prev Close
    151.89
  • Today's Open
    153.05
  • Day's Range
    153.05-157.69
  • Avg Vol (10-day)
    295.8K
  • Last (time)
    1:00p ET 11/27/20
  • Last (size)
    8.9K
  • 52-Wk Range
    88.17 - 257.97
    LowHigh
  • (02/05/20 - 09/28/20)
    78.36%
  • 85.3%
  • Market Cap
    5.3B
  • Shares Outstanding
    33.9M
  • -11.35
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.6
  • 76.19
  • (% of float 11/15/20)
    11.23

Latest News

November 27, 2020
5:00 pm ET
Globe Newswire
November 26, 2020
11:21 am ET
Globe Newswire
November 25, 2020
10:28 pm ET
Globe Newswire
7:04 am ET
Globe Newswire
November 24, 2020
8:04 pm ET
Newsfile
5:26 pm ET
Globe Newswire
12:00 pm ET
Globe Newswire
November 23, 2020
2:33 pm ET
Globe Newswire
November 22, 2020
1:00 am ET
Globe Newswire
November 21, 2020
2:30 pm ET
Newsfile
November 19, 2020
3:26 pm ET
Globe Newswire
11:26 am ET
Globe Newswire
November 18, 2020
6:00 pm ET
Globe Newswire
3:48 pm ET
Newsfile
3:33 pm ET
PR Newswire
3:17 pm ET
PR Newswire
November 17, 2020
9:33 am ET
Globe Newswire
November 16, 2020
9:52 pm ET
Globe Newswire
November 13, 2020
4:04 pm ET
Newsfile
November 12, 2020
3:22 pm ET
Globe Newswire
12:06 pm ET
Globe Newswire
November 11, 2020
6:00 pm ET
Globe Newswire
4:43 pm ET
Globe Newswire
3:18 pm ET
Newsfile
November 10, 2020
3:00 pm ET
Globe Newswire
November 09, 2020
9:09 am ET
Newsfile
6:45 am ET
Globe Newswire
6:15 am ET
Accesswire
November 08, 2020
2:46 am ET
Globe Newswire
November 06, 2020
8:50 pm ET
Globe Newswire
6:43 pm ET
Newsfile
4:13 pm ET
Globe Newswire
November 04, 2020
7:00 pm ET
Globe Newswire
6:30 pm ET
PR Newswire
6:19 pm ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.